A Multi-Center, Prospective, Observational Study of Patients Being Treated with ORGOVYX

Sponsor:

Sumitomo Pharma Switzerland GmbH

Code:

NCT05467176

Conditions

Prostate Cancer

Eligibility Criteria

Sex: Male

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Relugolix

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information